254 related articles for article (PubMed ID: 11140781)
1. Gilles de la Tourette syndrome: symptomatic treatment based on evidence.
Robertson MM; Stern JS
Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I60-75. PubMed ID: 11140781
[TBL] [Abstract][Full Text] [Related]
2. Gilles de la Tourette syndrome.
Gravino G
Ann Clin Psychiatry; 2013 Nov; 25(4):297-306. PubMed ID: 24199221
[TBL] [Abstract][Full Text] [Related]
3. The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.
Budman CL
Drugs; 2014 Jul; 74(11):1177-93. PubMed ID: 25034359
[TBL] [Abstract][Full Text] [Related]
4. Tourette Syndrome and Comorbid Neuropsychiatric Conditions.
Kumar A; Trescher W; Byler D
Curr Dev Disord Rep; 2016; 3(4):217-221. PubMed ID: 27891299
[TBL] [Abstract][Full Text] [Related]
5. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
[TBL] [Abstract][Full Text] [Related]
6. Randomized Sham Controlled Double-blind Trial of Repetitive Transcranial Magnetic Stimulation for Adults With Severe Tourette Syndrome.
Landeros-Weisenberger A; Mantovani A; Motlagh MG; de Alvarenga PG; Katsovich L; Leckman JF; Lisanby SH
Brain Stimul; 2015; 8(3):574-81. PubMed ID: 25912296
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders.
De Nadai AS; Storch EA; McGuire JF; Lewin AB; Murphy TK
J Cent Nerv Syst Dis; 2011; 3():125-42. PubMed ID: 23861643
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome.
Gulisano M; Calì PV; Cavanna AE; Eddy C; Rickards H; Rizzo R
Neurol Sci; 2011 Dec; 32(6):1213-7. PubMed ID: 21732066
[TBL] [Abstract][Full Text] [Related]
9. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.
Roessner V; Plessen KJ; Rothenberger A; Ludolph AG; Rizzo R; Skov L; Strand G; Stern JS; Termine C; Hoekstra PJ;
Eur Child Adolesc Psychiatry; 2011 Apr; 20(4):173-96. PubMed ID: 21445724
[TBL] [Abstract][Full Text] [Related]
10. Treatment strategies for tics in Tourette syndrome.
Eddy CM; Rickards HE; Cavanna AE
Ther Adv Neurol Disord; 2011 Jan; 4(1):25-45. PubMed ID: 21339906
[TBL] [Abstract][Full Text] [Related]
11. Dopamine receptor modulation of repetitive grooming actions in the rat: potential relevance for Tourette syndrome.
Taylor JL; Rajbhandari AK; Berridge KC; Aldridge JW
Brain Res; 2010 Mar; 1322():92-101. PubMed ID: 20114036
[TBL] [Abstract][Full Text] [Related]
12. [Tics and Tourette's syndrome throughout the life span].
Neuner I; Ludolph A
Nervenarzt; 2009 Nov; 80(11):1377-87; quiz 1388. PubMed ID: 19855949
[TBL] [Abstract][Full Text] [Related]
13. Pimozide for tics in Tourette's syndrome.
Pringsheim T; Marras C
Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD006996. PubMed ID: 19370666
[TBL] [Abstract][Full Text] [Related]
14. Neurosurgical strategies for Gilles de la Tourette's syndrome.
Mukhida K; Bishop M; Hong M; Mendez I
Neuropsychiatr Dis Treat; 2008 Dec; 4(6):1111-28. PubMed ID: 19337454
[TBL] [Abstract][Full Text] [Related]
15. Tourette's syndrome and role of tetrabenazine: review and personal experience.
Porta M; Sassi M; Cavallazzi M; Fornari M; Brambilla A; Servello D
Clin Drug Investig; 2008; 28(7):443-59. PubMed ID: 18544005
[TBL] [Abstract][Full Text] [Related]
16. Developmental psychopathology of children and adolescents with Tourette syndrome--impact of ADHD.
Roessner V; Becker A; Banaschewski T; Freeman RD; Rothenberger A;
Eur Child Adolesc Psychiatry; 2007 Jun; 16 Suppl 1():24-35. PubMed ID: 17665280
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric consequences of cardiovascular medications.
Huffman JC; Stern TA
Dialogues Clin Neurosci; 2007; 9(1):29-45. PubMed ID: 17506224
[TBL] [Abstract][Full Text] [Related]
18. Gilles de la Tourette's syndrome and its impact in the UK.
Stern JS; Burza S; Robertson MM
Postgrad Med J; 2005 Jan; 81(951):12-9. PubMed ID: 15640424
[TBL] [Abstract][Full Text] [Related]
19. Imidazoline binding sites on receptors and enzymes: emerging targets for novel antidepressant drugs?
Holt A
J Psychiatry Neurosci; 2003 Nov; 28(6):409-14. PubMed ID: 14631453
[No Abstract] [Full Text] [Related]
20. Pharmacological options for the treatment of Tourette's disorder.
Jiménez-Jiménez FJ; García-Ruiz PJ
Drugs; 2001; 61(15):2207-20. PubMed ID: 11772131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
